Page last updated: 2024-11-03

probenecid and Astrocytosis

probenecid has been researched along with Astrocytosis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
"These results support reactive gliosis as a means of striatal compensation for dopamine loss."1.32Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. ( Beales, M; Dervan, AG; McBean, GJ; Meredith, GE; Meshul, CK; Moore, C; Snyder, AK; Totterdell, S, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dervan, AG1
Meshul, CK1
Beales, M1
McBean, GJ1
Moore, C1
Totterdell, S1
Snyder, AK1
Meredith, GE1

Other Studies

1 other study available for probenecid and Astrocytosis

ArticleYear
Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease.
    Experimental neurology, 2004, Volume: 190, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Biological Transport; Cell Count;

2004